Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Immune serum globulin is a **sterile solution of immunoglobulin G (IgG) purified from pooled human plasma**, used primarily for passive immunization against infections such as hepatitis A, measles, varicella (chickenpox), and rubella, and as immunoglobulin replacement in individuals with antibody deficiencies. The product works by providing exogenous IgG antibodies, which confer **immediate, short-term protection** by neutralizing pathogens or their toxins, modulating immune responses, and supporting immune-deficient individuals. It is used both at replacement dosing (antibody deficiency) and higher immunomodulatory doses for various autoimmune, neurologic, hematologic, and dermatologic conditions. The mechanism involves **neutralization of viruses and toxins, modulation of Fc receptor function, inhibition of pathogenic autoantibodies, and anti-inflammatory immunomodulation**[1][2][3][7][9][10].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on immune serum globulin.